Authors: Gunthard, HF Havlir, DV Fiscus, S Zhang, ZQ Eron, J Mellors, J Gulick, R Frost, SDW Brown, AJL Schleif, W Valentine, F Jonas, L Meibohm, A Ignacio, CC Isaacs, R Gamagami, R Emini, E Haase, A Richman, DD Wong, JK

Citation: Hf. Gunthard et al., Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years, J INFEC DIS, 183(9), 2001, pp. 1318-1327

Authors: Gartland, M Gerstoft, J Goebel, F Clumeck, N Cooper, DA Gatell, J Gazzard, B Gerstoft, J Goebel, F Lange, J Montaner, J Reiss, P Rozenbaum, W Vella, S Beveridge, A Cooper, DA Duncombe, C Gold, J Haberl, M Clumeck, N Luyts, D Montaner, J Rachlis, A Marina, R Gerstoft, J Wandall, JH Elbrond, B Molina, JM Pialloux, G Rozenbaum, W Beauvais, L Goebel, FD Staszewski, S Bruns, I Hug, M Reiss, P Lange, J Frissen, PHJ van der Ende, ME Bosboom, M Baas, C Milazzo, F Moroni, M Panebianco, R Clotet, B Artigas, JMG Gonzalez-Lahoz, J Leal, M Rodriguez-Lopo, C Gandarias, B Gazzard, B Johnson, M McKinley, S Page, V Watkins, K Sandstrom, E Belsey, E Darbyshire, J Chodakewitz, J Isaacs, R Jonas, L Meibohm, A Coughlan, M Fiddian, P Gartland, M Harrigan, R Larder, B Maguire, M Millard, J Moore, S Patel, K Shortino, D Tisdale, M Vafidis, I Yeo, J

Citation: M. Gartland et al., AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients, AIDS, 14(4), 2000, pp. 367-374

Authors: Gulick, RM Mellors, JW Havlir, D Eron, JJ Meibohm, A Condra, JH Valentine, FT McMahon, D Gonzalez, C Jonas, L Emini, EA Chodakewitz, JA Isaacs, R Richman, DD

Citation: Rm. Gulick et al., 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine, ANN INT MED, 133(1), 2000, pp. 35-39

Authors: Cook, J Dasbach, E Coplan, P Markson, L Yin, DP Meibohm, A Nguyen, BY Chodakewitz, J Mellors, J

Citation: J. Cook et al., Modeling the long-term outcomes and costs of HIV Antiretroviral therapy using HIV RNA levels: Application to a clinical trial, AIDS RES H, 15(6), 1999, pp. 499-508

Authors: Hirsch, M Steigbigel, R Staszewski, S Mellors, J Scerpella, E Hirschel, B Lange, J Squires, K Rawlins, S Meibohm, A Leavitt, R

Citation: M. Hirsch et al., A randomized, controlled trial of indinavir, zidovudine, and lamivudine inadults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy, J INFEC DIS, 180(3), 1999, pp. 659-665